 CAMBRIDGE, Mass., April 27, 2021 GLOBE NEWSWIRE -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host a conference call at 8:00 AM EDT on May 10, 2021, to discuss its first quarter 2021 results and provide a business update. The event will be webcast live and can be accessed on the Investor Relations section of Constellations website at To participate in the live question-and-answer session, please dial 877 473-2077 domestic or 661 378-9662 international and refer to conference ID 8798968. 